H. Marqués de Valdecilla

Running trials

• Not yet recruiting

  Inotuzumab as Post-Trasplantation Therapy for Adult High-risk B-cell Precursor Acute Lymphoblastic Leukemia

  NCT07862946· Phase 2· Source

• Recruiting

  Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)

  NCT07478991· Phase 3· Source

• Recruiting

  Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST)

  NCT07045909· Phase 2· Source

• Recruiting

  Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults

  NCT04179929· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia2 recruiting
• Acute myeloid leukemia1 recruiting
• Multiple myeloma1 recruiting

Researchers

No researcher is linked here yet.